Classes
Publications
- Early and delayed cardioprotective intervention with dexrazoxane each show different potential for prevention of chronic anthracycline cardiotoxicity in rabbits2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Catalytic Inhibitors of Topoisomerase II Differently Modulate the Toxicity of Anthracyclines in Cardiac and Cancer Cells2013 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Protective effects of dexrazoxane against acute ischaemia/reperfusion injury of rat hearts2012 | Faculty of Medicine in Hradec Králové
- Comparison of clinically used and experimental iron chelators for protection against oxidative stress-induced cellular injury2010 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
- Dexrazoxane-afforded protection against chronic anthracycline cardiotoxicity in vivo: effective rescue of cardiomyocytes from apoptotic cell death +12009 | Faculty of Medicine in Hradec Králové
- Pyridoxal isonicotinoyl hydrazone (PIH) and its analogs as protectants against anthracycline-induced cardiotoxicity2008 | Faculty of Medicine in Hradec Králové, Central Library of Charles University
- Deferiprone does not protect against chronic anthracycline cardiotoxicity in vivo +12008 | Faculty of Medicine in Hradec Králové
- Anthracycline toxicity to cardiomyocytes or cancer cells is differently affected by iron chelation with salicylaldehyde isonicotinoyl hydrazone +12008 | Faculty of Medicine in Hradec Králové
- Evaluation of in vitro protection by salicylaldehyde isonicotinoyl hydrazone (SIH) against hydrogen peroxide-and anthracycline-induced toxicity to cardiac cellsPublication without faculty affiliation
- Primary prevention of chronic anthracycline cardiotoxicity with ACE inhibitor is temporarily effective in rabbits, but benefits wane in post-treatment follow-up2022 | Faculty of Pharmacy in Hradec Králové, Faculty of Medicine in Hradec Králové
Loading network view...